“Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Pooled Analysis of Two Phase 3, Randomized, Double-Blind Studies”. 2021. SKIN The Journal of Cutaneous Medicine 5 (1): s8. https://doi.org/10.25251/skin.5.supp.8.